Urinary Monocyte Chemoattractant Protein-1 in Patients With Alport Syndrome
Kidney Int Rep
.
2022 Feb 1;7(5):1112-1114.
doi: 10.1016/j.ekir.2022.01.1052.
eCollection 2022 May.
Authors
Clifford Kashtan
1
,
Asher Schachter
2
,
Lloyd Klickstein
3
,
Xin Liu
4
,
Lori Jennings
4
,
Nancy Finkel
4
Affiliations
1
Division of Pediatric Nephrology, Department of Pediatrics, University of Minnesota Medical School, Minneapolis, Minnesota, USA.
2
Visterra, Inc., Waltham, Massachusetts, USA.
3
Versanis Bio, Oakland, California, USA.
4
Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA.
PMID:
35571002
PMCID:
PMC9091606
DOI:
10.1016/j.ekir.2022.01.1052
No abstract available
Keywords:
Alport syndrome; urinary MCP-1; urinary biomarkers.